GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (NAS:OMCL) » Definitions » Piotroski F-Score

Omnicell (Omnicell) Piotroski F-Score

: 4 (As of Today)
View and export this data going back to 2001. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Omnicell has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Omnicell's Piotroski F-Score or its related term are showing as below:

OMCL' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 9
Current: 4

During the past 13 years, the highest Piotroski F-Score of Omnicell was 9. The lowest was 4. And the median was 5.


Omnicell Piotroski F-Score Historical Data

The historical data trend for Omnicell's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 4.00 6.00 5.00 4.00

Omnicell Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 4.00 5.00 5.00 4.00

Competitive Comparison

For the Health Information Services subindustry, Omnicell's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell Piotroski F-Score Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Omnicell's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -15 + 3.451 + 5.553 + -14.375 = $-20 Mil.
Cash Flow from Operations was 12.77 + 72.903 + 57.007 + 38.414 = $181 Mil.
Revenue was 290.629 + 298.973 + 298.663 + 258.847 = $1,147 Mil.
Gross Profit was 125.029 + 134.443 + 131.964 + 105.404 = $497 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(2210.758 + 2250.838 + 2193.872 + 2221.575 + 2226.878) / 5 = $2220.7842 Mil.
Total Assets at the begining of this year (Dec22) was $2,211 Mil.
Long-Term Debt & Capital Lease Obligation was $604 Mil.
Total Current Assets was $928 Mil.
Total Current Liabilities was $368 Mil.
Net Income was 8.213 + 9.069 + 16.774 + -28.408 = $6 Mil.

Revenue was 318.828 + 331.386 + 348.059 + 297.674 = $1,296 Mil.
Gross Profit was 150.047 + 158.092 + 159.095 + 121.753 = $589 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(2142.496 + 2122.588 + 2131.458 + 2179.685 + 2210.758) / 5 = $2157.397 Mil.
Total Assets at the begining of last year (Dec21) was $2,142 Mil.
Long-Term Debt & Capital Lease Obligation was $606 Mil.
Total Current Assets was $882 Mil.
Total Current Liabilities was $428 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Omnicell's current Net Income (TTM) was -20. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Omnicell's current Cash Flow from Operations (TTM) was 181. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-20.371/2210.758
=-0.00921449

ROA (Last Year)=Net Income/Total Assets (Dec21)
=5.648/2142.496
=0.00263618

Omnicell's return on assets of this year was -0.00921449. Omnicell's return on assets of last year was 0.00263618. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Omnicell's current Net Income (TTM) was -20. Omnicell's current Cash Flow from Operations (TTM) was 181. ==> 181 > -20 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=603.572/2220.7842
=0.27178327

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=605.976/2157.397
=0.28088293

Omnicell's gearing of this year was 0.27178327. Omnicell's gearing of last year was 0.28088293. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=927.571/367.792
=2.52199885

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=881.812/428.446
=2.05816369

Omnicell's current ratio of this year was 2.52199885. Omnicell's current ratio of last year was 2.05816369. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Omnicell's number of shares in issue this year was 45.497. Omnicell's number of shares in issue last year was 44.68. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=496.84/1147.112
=0.43312248

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=588.987/1295.947
=0.45448386

Omnicell's gross margin of this year was 0.43312248. Omnicell's gross margin of last year was 0.45448386. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=1147.112/2210.758
=0.51887724

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=1295.947/2142.496
=0.60487721

Omnicell's asset turnover of this year was 0.51887724. Omnicell's asset turnover of last year was 0.60487721. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+1+0+0+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Omnicell has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Omnicell  (NAS:OMCL) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Omnicell Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Omnicell's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicell (Omnicell) Business Description

Traded in Other Exchanges
Address
2625 Augustine Drive, Suite 301, Santa Clara, CA, USA, 95054
Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.
Executives
Kaushik Ghoshal director 9001 SPECTRUM CENTER BLVD, SAN DIEGO CA 92123
Christine Marie Mellon officer: EVP, Chief People Officer 590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Randall A Lipps director, officer: President and CEO 1101 EAST MEADOW DR, PALO ALTO CA 94303
Nchacha Etta officer: EVP & CFO 4220 NORTH FREEWAY, FORT WORTH TX 76137
Joanne B Bauer director 1400 HOLCOMB BRIDGE ROAD, ROSWELL GA 30076-2199
Scott Peter Seidelmann officer: EVP, Chief Commercial Officer 590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Peter J. Kuipers officer: Executive V.P. CFO 590 E. MIDDLEFEILD ROAD, MOUNTAIN VIEW CA 94043
Mary Garrett director ETHAN ALLEN DRIVE, DANBURY CT 06811
Manley Corey J officer: SR. VP & CHIEF LEGAL OFFICER 590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Dan S Johnston officer: V.P., Legal & General Counsel
Joseph Brian Spears officer: Chief Accounting Officer & VP 590 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
James T Judson officer: VP Finance & Acting CFO C/O OMNICELL, INC., 1201 CHARLESTON ROAD, MOUNTAIN VIEW CA 94043
Robin Gene Seim officer: V.P., Finance & CFO 1201 CHARLESTON ROAD, MOUNTAIN VIEW CA 94043
Edward Peter Bousa director 280 CONGRESS STREET, BOSTON MA 02210
Nhat H Ngo officer: VP, Strategy & Business Dev. 490 NORTH WIGET LANE, WALNUT CREEK CA 94598